Earnings Beats

Patterson Companies, Inc. (NASDAQ: PDCO) is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further....

Trinity Biotech plc (NASDAQ: TRIB) recently provided an update on its continued development of its glucose biosensor technology. Earlier this year, the company was granted a European patent for a novel method that enhances the performance of its glucose biosensor. Recent testing of this...

Virco Manufacturing Corporation (NASDAQ: VIRC) reported mixed second-quarter fiscal 2024 (ended July 31, 2024) results, wherein earnings surpassed the Zacks Consensus Estimate but sales missed the same. Following the results, the company's shares lost 9.3% on Sept. 09. On a year-over-year basis...

Shares of Oracle Corp (NYSE:ORCL) climbed in early trading on Tuesday, after the company reported upbeat fiscal first-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. JMP Securities analyst Patrick Walravens upgraded the...

Shares of Rocket Pharmaceuticals (NASDAQ: RCKT) have plunged 32.9% in the past six months compared with the industry's decline of 3.4%. The company is developing its gene therapy candidate, Kresladi (marnetegragene autotemcel) to treat patients with severe leukocyte adhesion deficiency-I (LAD-I...

Shares of Immunovant (NASDAQ: IMVT) are rising in the pre-market hours on Sept. 9 after the company announced positive data from the mid-stage study of its investigational candidate, batoclimab, which is being developed for Graves' Disease. IMVT's Batoclimab Shows Superior Efficacy in GD...

SAP SE's (NYSE: SAP) stock is continuing its upward trajectory, with a gain of 36.7% in the year to date compared with 13.3% and 6.2% growth of the S&P 500 composite and the sub-industry, respectively. The company is currently trading at a nearly 4.5% discount to its 52-week high of $221.24...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) announced that the FDA has accepted its resubmitted new drug application (NDA) seeking approval for AXS-07 for the acute treatment of migraine. A final decision from the regulatory body is expected on Jan. 31, 2025. The FDA has designated the NDA...

Quanex Building Products (NYSE: NX) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings...

Broadcom Inc. (NASDAQ: AVGO) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings...

PPG Industries Inc. (NYSE: PPG) has announced that it will demonstrate its digital and sustainable solutions at Automechanika Frankfurt 2024, the world's premier trade fair for the automotive aftermarket, which will be held at the Messe Frankfurt exhibition center in Germany from  Sept. 10...

Eastman Chemical Company (NYSE: EMN) is benefiting from cost-cutting and productivity actions as well as its innovation-driven growth model amid challenges from soft demand in certain markets. Shares of EMN are up 22.1% over the past year compared with a 7.4% decline of its industry. Image Source...

Shares of Docusign Inc (NASDAQ:DOCU) were climbing over 3.2% in early trading on Friday, after the company reported upbeat second-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets analyst Rishi Jaluria...

Shares of UiPath Inc (NYSE:PATH) are down Friday despite the company’s reporting in-line fiscal second-quarter results. Here are some key analyst takeaways: BMO Capital Markets analyst Keith Bachman maintained a Market Perform rating, while raising the price target from $14 to $15. DA...